BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND AR, P10275, 367, ENSG00000169083, DHTR, SBMA, HUMARA, SMAX1, RP11-383C12_1, TFM, AIS, NR3C4, KD
60135 results:

  • 1. Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression.
    Shaw TI; Wagner J; Tian L; Wickman E; Poudel S; Wang J; Paul R; Koo SC; Lu M; Sheppard H; Fan Y; O'Neill FH; Lau CC; Zhou X; Zhang J; Gottschalk S
    Nat Commun; 2024 May; 15(1):3732. PubMed ID: 38702309
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation.
    Gassner T; Chittilappilly C; Pirich T; Neuditschko B; Hackner K; Lind J; Aksoy O; Graichen U; Klee S; Herzog F; Wiesner C; Errhalt P; Pecherstorfer M; Podar K; Vallet S
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38702145
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Incidentally detected follicular thyroid carcinoma mimicking parathyroid adenoma on Tc-99m MIBI scan: A case report.
    Han YH; Jeong HJ; Lee SY; Lim ST
    Medicine (Baltimore); 2024 May; 103(18):e38107. PubMed ID: 38701245
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors.
    Lou J; Gong B; Li Y; Guo Y; Li L; Wang J; Liu W; You Z; Zhang H; Pan F; Liang B; Yang L; Zhou G
    Front Immunol; 2024; 15():1332303. PubMed ID: 38698843
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China.
    Han X; Jiang X; He J; Zheng G; Xiong Y; Wen Y; Yang Y; He D; Chen Q; Zhao Y; Li Y; Wu W; Cai Z
    Cancer Med; 2024 May; 13(9):e7232. PubMed ID: 38698679
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Three-dimensional printed custom-made modular talus prosthesis in patients with talus malignant tumor resection.
    He X; Lu M; Zou C; Li Z; Gong T; Kenmegne GR; Wang Y; Luo Y; Zhou Y; Min L; Tu C
    J Orthop Surg Res; 2024 May; 19(1):273. PubMed ID: 38698477
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Bioaccumulation and health risk assessment of trace elements in Tilapia (Oreochromis mossambicus) from selected inland water bodies.
    Balamanikandan V; Shalini R; Arisekar U; Shakila RJ; Padmavathy P; Sivaraman B; Devanesan S; Sundhar S; AlSalhi MS; Mythili R; Kim W
    Environ Geochem Health; 2024 May; 46(6):187. PubMed ID: 38696018
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development of Aptamer-DNAzyme based metal-nucleic acid frameworks for gastric cancer therapy.
    Yan J; Bhadane R; Ran M; Ma X; Li Y; Zheng D; Salo-Ahen OMH; Zhang H
    Nat Commun; 2024 May; 15(1):3684. PubMed ID: 38693181
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Structure-sparing resection for the management of cervical chordomas: a retrospective institutional series.
    Levy AS; Jamshidi AM; Costello MC; Levi AD
    Neurosurg Focus; 2024 May; 56(5):E6. PubMed ID: 38691869
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.
    Banu MA; Raza SM; Amini M; Seaman S; Rubino F; Snyder R; Patel S; DeMonte F; Conley AP
    Neurosurg Focus; 2024 May; 56(5):E15. PubMed ID: 38691867
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characterizing the presentation, management, and clinical outcomes of patients with intradural spinal chordomas: a systematic review.
    Saint-Germain MA; Kramer P; Weber-Levine C; Jiang K; Al-Mistarehi AH; Redmond KJ; Lee SH; Bettegowda C; Theodore N; Lubelski D
    Neurosurg Focus; 2024 May; 56(5):E14. PubMed ID: 38691865
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection.
    Ghaith AK; Nguyen R; El-Hajj VG; Montaser A; De Biase G; Ravindran K; Perez-Vega C; Lee SJ; Dominari A; Battistin U; Suárez-Meade P; Moussalem C; Patel NP; Kalani MA; Clarke MJ; Rose PS; Bydon M; Abode-Iyamah K; Akinduro OO
    Neurosurg Focus; 2024 May; 56(5):E9. PubMed ID: 38691864
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Multidisciplinary surgical considerations for en bloc resection of sacral chordoma: review of recent advances and a contemporary single-center series.
    Schroeder C; de Lomba WC; Leary OP; De la Garza Ramos R; Gillette JS; Miner TJ; Woo AS; Fridley JS; Gokaslan ZL; Zadnik Sullivan PL
    Neurosurg Focus; 2024 May; 56(5):E7. PubMed ID: 38691863
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Optimizing radiotherapy strategies for skull base chordoma: a comprehensive meta-analysis and systematic review of treatment modalities and outcomes.
    Palavani LB; Borges P; Andreão FF; Borges J; Batista S; Oliveira LB; Ferreira MY; Reis PCA; Pontes J; Negri H; Beer-Furlan A; Krishna C; Bertani R; Rassi MS
    Neurosurg Focus; 2024 May; 56(5):E11. PubMed ID: 38691862
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Supramarginal resection of skull base chordomas: proof of concept and preliminary outcomes.
    Rychen J; Constanzo F; Xu Y; Johnstone TM; Bex A; Rinaldi M; Lee CK; Fernandez-Miranda JC
    Neurosurg Focus; 2024 May; 56(5):E3. PubMed ID: 38691859
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A comparison of endoscopic endonasal versus open approaches for skull base chordoma: a comprehensive National cancer Database analysis.
    Soffer JM; Ulloa R; Chen S; Ziltzer RS; Patel VA; Polster SP
    Neurosurg Focus; 2024 May; 56(5):E5. PubMed ID: 38691856
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The burden of skull base chordomas: insights from a meta-analysis of observational studies.
    Fiore G; Porto E; Bertani GA; Marcus HJ; Saladino A; Pradilla G; DiMeco F; Locatelli M
    Neurosurg Focus; 2024 May; 56(5):E13. PubMed ID: 38691853
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome.
    Consiglieri G; Tucci F; De Pellegrin M; Guerrini B; Cattoni A; Risca G; Scarparo S; Sarzana M; Pontesilli S; Mellone R; Gasperini S; Galimberti S; Silvani P; Filisetti C; Darin S; Forni G; Miglietta S; Santi L; Facchini M; Corti A; Fumagalli F; Cicalese MP; Calbi V; Migliavacca M; Barzaghi F; Ferrua F; Gallo V; Recupero S; Canarutto D; Doglio M; Tedesco L; Volpi N; Rovelli A; la Marca G; Valsecchi MG; Zancan S; Ciceri F; Naldini L; Baldoli C; Parini R; Gentner B; Aiuti A; Bernardo ME
    Sci Transl Med; 2024 May; 16(745):eadi8214. PubMed ID: 38691622
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Plant-Based Diets and Disease Progression in Men With Prostate cancer.
    Liu VN; Van Blarigan EL; Zhang L; Graff RE; Loeb S; Langlais CS; Cowan JE; Carroll PR; Chan JM; Kenfield SA
    JAMA Netw Open; 2024 May; 7(5):e249053. PubMed ID: 38691361
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report.
    Zhang Y; Hu M; Guo C; Yang X; Xiang S; Xu H
    Front Endocrinol (Lausanne); 2024; 15():1373794. PubMed ID: 38689735
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3007.